The pharmaceutical business sector continued to rise, with Easy Pharmaceuticals going up and down. People's Tongtai had previously closed the market. Chinese Health and C&D caused new increases of more than 10%, while Hefu China, Dajia Weikang, Shuyu Pingmin, Luyan Pharmaceutical, and Saili Healthcare followed suit.

The pharmaceutical business sector continued to rise, with Easy Pharmaceuticals going up and down. People's Tongtai had previously closed the market. Chinese Health and C&D caused new increases of more than 10%, while Hefu China, Dajia Weikang, Shuyu Pingmin, Luyan Pharmaceutical, and Saili Healthcare followed suit.